Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mosa Meat pioneered the world’s first cultured beef burger in 2013 and has since developed scalable processes to produce real beef directly from cow cells without animal slaughter. The company has removed all animal components from its process, including fetal bovine serum, making its products more ethical and sustainable. It focuses on bringing down costs through innovations like serum-free media and aims to enter markets starting with Europe and Singapore upon regulatory approval. As of early/mid 2025, it remains pre-commercial but has filed for market authorization of its cultivated fat ingredient—the first such submission in the EU.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mosa Meat.